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Infection with herpes simplex virus 2 (HSV-2) is a primary cause of genital lesions. This viral 
infection is highly prevalent worldwide, affecting 17% of American adults and as high as 95% in 
some populations, such as HIV-positive individuals and female sex workers. Aside from causing 
genital lesions, HSV-2 infection also increases a person's susceptibility to HIV infection. Much effort 
has been dedicated to elucidating details of the local innate and adaptive immune responses to 
HSV-2 infection and reactivation. Human studies have predominantly involved characterizing the T-
cell responses to HSV-2 in the blood, skin and eye. The characteristics of the T-cell repertoire at the 
site of infection and reactivation were recently reported by researchers from the Vaccine and 
Infectious Disease Division in the journal Mucosal Immunology. A detailed analysis of the local T-cell 
response to HSV-2 infection in the female genital tract was possible by obtaining cells from the 
cervixes of HSV-2-positive females.  
"The need for a vaccine for HSV-2 is great," said lead author of the study Dr. Christine Posavad, 
"and we believe the knowledge gained in uncovering mechanisms of T-cell protection in the female 
reproductive tract will inform the design of prophylactic vaccines and novel immunotherapies 
directed at HSV-2." Indeed, the development of any therapeutic intervention directed at treating or 
preventing HSV-2 infection will likely rely heavily on data about the local immune responses to the 
virus observed at the site of infection and reactivation. 
The researchers obtained cervical cytobrush samples from HSV-2-infected and seronegative control 
subjects. T cells from these samples were expanded in vitro in order to test the cell phenotype and 
the ability of the cells to recognize HSV-2 antigens. Thirty HSV-2-infected patients provided at least 
two cervical cytobrush samples. A fairly high proportion of these samples (65%) contained T cells 
that proliferated in response to HSV-2 in lymphoproliferative assays. 
Next, the researchers looked at the T-cell phenotype in the expanded T-cell populations. Of the 
CD3
+
 T cells obtained from the cervix that were specific for HSV-2, 91.3% of them on average were 
CD4
+
 T helper cells, while a median of 3.9% were CD8
+
 cytotoxic T cells. It is possible that 
discrepancies between the tendencies of the different cell types to expand after sample collection 
could have played a minor role in this finding. However, importantly the CD4
+
 T cells had a greater 
breadth of antigenic recognition of HSV-2 peptides. By looking at the phenotype of T cells that 
reactivated following incubation with pools of HSV-2 peptides, the researchers were able to compare 
the CD4
+
 and CD8
+
 cell subsets. The CD4
+
 T cells were found to recognize substantially more HSV-
2 peptides than the CD8
+
 T cells (see figure). Thus, the CD4
+
 T cells not only made up a larger 
proportion of the CD3
+
 cervical T-cell population, but also displayed a greater breadth of antigenic 
recognition of HSV-2 than the CD8
+
 T cells. 
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Dr. Posavad explained, "Our data suggest that T-cell responses to HSV-2 are common and resident 
at mucosal sites of HSV-2 exposure and reactivation." Future studies will focus on the specific roles 
played by these T-cell populations during infection and reactivation of HSV-2, to inform potential 
vaccination strategies to prevent HSV-2 acquisition. "Our goal is to understand the mechanism of 
local containment of HSV-2 and to determine how resident memory T cells are established and 
maintained in the female reproductive tract," said Dr. Posavad, "To achieve this goal, we will need to 
analyze T-cell responses ex vivo, and we are currently optimizing these procedures in the lab." 
Posavad CM, Zhao L, Mueller DE, Stevens CE, Huang ML, Wald A, Corey L. 2014. Persistence of 
mucosal T-cell responses to herpes simplex virus type 2 in the female genital tract. Mucosal 
immunology. doi: 10.1038/mi.2014.47. [Epub ahead of print]. 
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Image provided by Dr. Christine Posavad. 
 
T cells expanded from cervical cytobrush samples obtained one month apart from an HSV-2-infected 
patient were assayed for antigenic recognition of HSV-2 and pools of HSV-2 peptides. The CD4+ T 
cell subsets (above), in addition to comprising a much larger proportion of the CD3+ T cell 
population, exhibited a much larger breadth of HSV-2 recognition than the CD8+ T cells (below). 
CD4+ and CD8+ T cells directed at the same HSV-2 peptide could be detected in the cervix over the 
one-month study period suggesting that they are resident and persist in the female genital tract. 
 
